Marc Goodman

Stock Analyst at Leerink Partners

(2.17)
# 1196
Out of 5,441 analysts
143
Total ratings
Success rate
Average return
40 Stocks
Name Action PT Current % Upside Ratings Updated
BHVN Biohaven
Maintains: Outperform
60 50
13.43 272.3% 7 Aug 12, 2025
AMLX Amylyx Pharmaceutica...
Upgrades: Outperform
4 10
7.81 28.04% 5 May 7, 2025
OPT Opthea
Downgrades: Market Perform
12 1
3.41 -70.67% 2 Mar 25, 2025
AXSM Axsome Therapeutics
Maintains: Outperform
110 150
103.95 44.3% 7 Feb 10, 2025
RLMD Relmada Therapeutics
Downgrades: Market Perform
10 1
0.56 78.57% 3 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
32
38.72 -17.36% 1 Apr 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
69.7 -64.13% 1 Jul 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
n/a n/a 5 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
13.91 259.45% 1 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 23
0.55 4081.82% 4 Jan 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
18 20
5.76 247.22% 3 Jan 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 1
1.1 -9.09% 4 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
100 115
123.99 -7.25% 4 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
270 310
128.03 142.13% 11 Oct 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 4
5.11 -21.72% 4 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 12
12.79 -6.18% 2 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 46
34.12 34.82% 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
170 270
329.83 -18.14% 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 21
24.83 -15.42% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 210
110.76 89.6% 5 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
50 40
8.68 360.83% 5 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
2.05 387.8% 2 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
24 27
26.55 1.69% 5 Apr 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 70
131.87 -46.92% 3 Apr 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
10 2
1.35 48.15% 4 Mar 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 15
5.24 186.26% 2 Dec 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
37 32
26.68 19.94% 3 Dec 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
322 70
5.5 1172.73% 3 May 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
200 220
n/a n/a 1 Feb 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
300 270
498.4 -45.83% 5 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
79 96
198.62 -51.67% 5 Nov 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
189 203
n/a n/a 5 Nov 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
72 0
n/a n/a 2 May 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 13, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 7
n/a n/a 4 Nov 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
12 16
n/a n/a 2 Oct 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
72 67
80.06 -16.31% 3 Oct 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
19 15
n/a n/a 2 Oct 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
84 98
22.01 345.25% 3 Oct 5, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Mar 20, 2017